Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Should You Buy This Blue Chip Stock's Dip Hand Over Fist?: https://g.foolcdn.com/editorial/images/770902/medical-technician.jpg
Should You Buy This Blue Chip Stock's Dip Hand Over Fist?

Cyberattacks can disrupt corporations, and you've seen that play out in recent weeks. UnitedHealth Group (NYSE: UNH) fell roughly $14 billion behind in paying claims after a hacker group attacked

2 Stocks Down 30% and 27% to Buy and Hold: https://g.foolcdn.com/editorial/images/770988/doctor-vaccinating-a-patient.jpg
2 Stocks Down 30% and 27% to Buy and Hold

No pair of companies dominated the COVID-19 vaccine market quite like Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). Both saw their revenue and earnings skyrocket, along with their share prices, as

Better Recovery Story Buy: Pfizer vs Moderna: https://g.foolcdn.com/editorial/images/771147/gettyimages-1292931102.jpg
Better Recovery Story Buy: Pfizer vs Moderna

A few years ago, both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were flying high: from an earnings and share performance perspective. They each sold a leading coronavirus vaccine -- and Pfizer

Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance: https://g.foolcdn.com/editorial/images/771135/two-people-use-devices-at-home-getty.jpg
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance

If you're an everyday investor looking for stocks that can deliver steadily rising dividend payouts over long periods, the healthcare sector is the right place to begin your search. People get sick

1 Top Growth Stock to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/770717/doctor-with-patient-talking.jpg
1 Top Growth Stock to Buy and Hold Forever

Biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) has outperformed the S&P 500 in the past three, five, and 10 years. That's not a fluke: The drugmaker has been highly successful financially while

This Beleaguered Ultra-High-Yield Dividend Stock Might Soon Get Some Much-Needed Relief: https://g.foolcdn.com/editorial/images/770905/a-person-making-financial-calculations.jpg
This Beleaguered Ultra-High-Yield Dividend Stock Might Soon Get Some Much-Needed Relief

Medical Properties Trust (NYSE: MPW) has fallen on hard times over the past few years. Shares of the hospital-focused real estate investment trust (REIT) have lost more than 80% of their value from

3 Unstoppable Stocks to Buy Hand Over Fist in April: https://g.foolcdn.com/editorial/images/771014/happy-woman-because-the-stock-market-went-up.jpg
3 Unstoppable Stocks to Buy Hand Over Fist in April

The "it factor." Some stocks have it. Others don't. But when you find stocks with the "it factor," you'll want to load up on them.

Three Motley Fool contributors believe they've identified three

Why Medical Properties Trust Stock Popped Today: https://g.foolcdn.com/editorial/images/770930/rent-blocks-real-estate-rental.jpg
Why Medical Properties Trust Stock Popped Today

Shares of Medical Properties Trust (NYSE: MPW) soared 18.6% on Wednesday after the largest tenant of the healthcare facilities-focused real estate investment trust (REIT) announced a deal to sell

2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever: https://g.foolcdn.com/editorial/images/770308/individual-investors-at-home-getty.jpg
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever

Few things are more satisfying than watching a steadily growing stream of passive income flow into your brokerage account. If you've been holding back from investing because you think you can't

Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?: https://g.foolcdn.com/editorial/images/770269/sell-stock.jpg
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?

Cathie Wood and high dividend yields go together like... well, it's hard to finish that sentence because they don't go together at all. Wood and her Ark Invest funds are known for investing in

1 Magnificent Dividend Stock to Buy and Hold: https://g.foolcdn.com/editorial/images/769890/patient-and-doctor-talking.jpg
1 Magnificent Dividend Stock to Buy and Hold

There are plenty of dividend stocks on the market. However, some raise their payouts irregularly, while others don't have businesses that look robust enough to support payout growth for a long time

A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now: https://g.foolcdn.com/editorial/images/769710/dog-with-owners-looking-at-laptop.jpg
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now

Does a rising tide really lift all boats? We could soon find out if the adage applies to the stock market.

A bull market is now well underway. The S&P 500 has soared more than 30% over the last 12

2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?: https://g.foolcdn.com/editorial/images/769667/a-person-sitting-at-their-home-office-desk-using-a-laptop-computer-getty.jpg
2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?

Investors looking for stocks that can deliver heaps of passive income might want to turn their heads toward the healthcare sector. Right now, there are a couple of beaten-down stocks offering

Will Pfizer Be a Trillion-Dollar Stock by 2035?: https://g.foolcdn.com/editorial/images/769917/scientists-in-a-lab-monitor-microscope.jpg
Will Pfizer Be a Trillion-Dollar Stock by 2035?

Some investors look at Pfizer (NYSE: PFE) as a has-been. That's understandable in some ways. Sales for the company's once-formidable COVID-19 franchise have tanked. So have Pfizer's overall revenue

Want Decades of Passive Income? 2 Stocks to Buy Now.: https://g.foolcdn.com/editorial/images/769462/physician-shaking-patients-hand.jpg
Want Decades of Passive Income? 2 Stocks to Buy Now.

Dividend-paying stocks have generally outperformed those that don't pay dividends over the long term. That's partly because maintaining a healthy dividend requires a solid underlying business. And

Why Illumina Stock Zoomed Higher on Thursday: https://g.foolcdn.com/editorial/images/770227/medical-professional-working-at-a-computer-terminal.jpg
Why Illumina Stock Zoomed Higher on Thursday

A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P

Bull Market and Beyond: 2 Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/769484/doctor-smiling-and-holding-patients-hand.jpg
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever

Investors are enjoying the ongoing bull run. The S&P 500 and Nasdaq Composite recently hit all-time highs. Though that's pretty exciting, bull markets don't last forever. Equities that can perform

Is Pfizer the Best Dividend Stock for You?: https://g.foolcdn.com/editorial/images/769786/a-couple-reviewing-a-document-at-home.jpg
Is Pfizer the Best Dividend Stock for You?

If a dividend stock is struggling and falling in value, that pushes its yield up. This happens because while you are getting the same dividend, it is now costing you less money to acquire it. As

Is Amgen Stock a Buy Now?: https://g.foolcdn.com/editorial/images/769464/physician-giving-medicine-to-elderly-patient.jpg
Is Amgen Stock a Buy Now?

Biotech giant Amgen (NASDAQ: AMGN) isn't starting the year on a strong note. The company's shares are down by 5% since Jan. 1. It has dealt with some issues lately, especially subpar financial

Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors: https://mms.businesswire.com/media/20240320863840/en/2072794/5/2022_HUMANA_C2-Day3-SC12-2_Single-Single-Porch_0054_AQ1_original.jpg
Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors


Humana Inc. (NYSE: HUM) and DUOS, a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health outcomes for Louisiana Veteran

5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move: https://g.foolcdn.com/editorial/images/769387/light-bulb-drawings-with-a-person-thinking.jpg
5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move

Pfizer (NYSE: PFE) has seen its better days. Shares of the big drugmaker have plunged more than 50% from the highs set in late 2021. The pharma stock is down more than 30% over the last 12 months

2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now: https://g.foolcdn.com/editorial/images/769170/pharmacist-talking-to-patient.jpg
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

There are many ways to spend $1,000. One could buy a brand-new flat-screen television, play the lottery, or keep it in a savings account. For people trying to increase their capital, though

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation: https://g.foolcdn.com/editorial/images/769331/young-woman-smiling-hands-behind-head.jpg
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Investors can be procrastinators. It's easy to get caught up in analyzing stocks so much that people put off buying them. But that doesn't have to be the case.

Three Motley Fool contributors have

2 Top Dividend Stocks to Buy Hand Over Fist: https://g.foolcdn.com/editorial/images/769084/physician-giving-medicine-to-elderly-patient.jpg
2 Top Dividend Stocks to Buy Hand Over Fist

Finding high-yielding companies isn't everything when investing in dividend stocks. Sometimes, companies' yields increase after their share prices drop significantly, which can occasionally be a

Is Pfizer Stock a Millionaire Maker?: https://g.foolcdn.com/editorial/images/768804/a-team-of-scientists-reviewing-results-in-a-lab.jpg
Is Pfizer Stock a Millionaire Maker?

The stock market is at record levels these days, but one company that isn't reflecting that optimism is Pfizer (NYSE: PFE). Shares of the pharma giant are down 28% over the past 12 months as